Area of research
Applied Microbiology and Biotechnology · Infectious Diseases
Research interest
Research interests include Medicine, Antibiotic resistance, Antibiotics, Business, Computer science, and Antimicrobial.
Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillance
A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England
Comparison of antibiotic provision associated with acute sore throat symptom management in community pharmacies in Wales and England: a natural policy experiment
The appropriateness of self-care policy for urinary tract infections among women from racialised minorities and low-income households in the United Kingdom: A qualitative study
C-reactive protein diagnostic test uptake in primary care: a qualitative study of the UK’s 2019–2024 AMR National Action Plan and lessons learnt from Sweden, the Netherlands and British Columbia
(Re)Acting (to) the crisis: A comparative analysis of crisis framing in obesity, climate change, antimicrobial resistance, and the UK cost-of-living crisis
Governing Integrated Health and Social Care: An Analysis of Experiences in Three European Countries
Antimicrobial resistance: action must shift towards prevention
Equity in evidence synthesis: You can't play on broken strings
Progress and Challenges: Implementation of the UK Antimicrobial Resistance National Action Plan 2019–2024 within the Beef Cattle Sub-Sector
Why is the UK subscription model for antibiotics considered successful?
Do you see the problem? Visualising a generalised ‘complex local system’ of antibiotic prescribing across the United Kingdom using qualitative interview data
The WHO costing and budgeting tool for national action plans on antimicrobial resistance—a practical addition to the WHOle toolkit
Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END)
The antibiotic subscription model: fostering innovation or repackaging old drugs?
Antimicrobial resistance and COVID-19: Intersections and implications
Sankey diagrams can clarify ‘evidence attrition’: A systematic review and meta-analysis of the effectiveness of rapid diagnostic tests for antimicrobial resistance
NIMble innovation—a networked model for public antibiotic trials
Antimicrobial resistance at the G7
Quality and Utility of Information Captured by Surveillance Systems Relevant to Antimicrobial Resistance (AMR): A Systematic Review
OP59 Stakeholder narratives of ‘problems’ and ‘solutions’: analysing the 2018 Health and social care committee antimicrobial resistance submissions in the United Kingdom
Mathematical modelling for antibiotic resistance control policy: do we know enough?
Subscription model for antibiotic development
Antibiotic resistance: don’t blame patients
Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling Study
Measuring the impact of Ebola control measures in Sierra Leone